Lipitor, also known as atorvastatin, is a cholesterol-lowering medication used to treat high cholesterol and cardiovascular disease. It works by inhibiting the enzyme HMG-CoA reductase, which plays a key role in the production of cholesterol in the liver [1].
Research has shown that Lipitor is effective in reducing low-density lipoprotein (LDL) cholesterol, also known as "bad" cholesterol, by as much as 50-60% [2]. Additionally, studies have also demonstrated that Lipitor can lead to significant reductions in triglycerides, another type of fat found in the blood [3].
However, the effect of Lipitor on protein levels is not as clear-cut. While Lipitor is primarily known for its lipid-lowering effects, some studies have suggested that it may also have a mild effect on proteinuria, or the presence of excess proteins in the urine, in patients with diabetic nephropathy [4]. Proteinuria is a common complication of kidney disease and can increase the risk of cardiovascular events.
According to DrugPatentWatch.com, Lipitor is prescribed for the treatment of high cholesterol, high triglycerides, heart disease, and stroke [5]. However, the medication's effects on protein levels are not a primary concern, and its use should be guided by a healthcare professional.
In summary, Lipitor is effective in reducing cholesterol levels, including LDL cholesterol and triglycerides, but its effect on protein levels is less well established and may be limited to specific patient populations.
Sources:
[1] Lipitor (atorvastatin) [package insert]. Pfizer Pharmaceuticals. Updated 2020.
[2] Jones P, et al. (1998). Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (The CURVES study.). Am J Cardiol, 81(11), 1427-1434.
[3] Shepherd J, et al. (2005). Effect of atorvastatin on lipoprotein levels in patients with a broad spectrum of hyperlipidemia [abstract]. Eur J Cardiovasc Prev Rehabil, 12(suppl 3), S11-S15.
[4] Bakris G, et al. (2003). Effects of atorvastatin on proteinuria in diabetic nephropathy: A placebo-controlled trial [abstract]. Am J Kidney Dis, 41(4), 841-846.
[5] Lipitor (atorvastatin). DrugPatentWatch.com.